CVE-2025-50675
Published Aug 7, 2025
CVSS 3.1 · 7.8 High
EPSS < 1%
KEV · Not listed
Description
GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An attacker with user-level access can exploit this misconfiguration by replacing or modifying the uninstaller (GPsetup64_17028.exe) with a malicious version. While the application itself runs in the user's context, the uninstaller is typically executed with administrative privileges when an administrator attempts to uninstall the software. By exploiting this flaw, an attacker could gain administrative privileges and execute arbitrary code in the context of the admin, resulting in privilege escalation.
Affected Products
-
CVE record
-
NVD configurations
No data
-
Red Hat packages
No data
-
OpenCVE enrichment
No data
Default status is the baseline for the product, each version can override it (e.g. patched versions marked unaffected).
| Vendor | Product | Default status | Versions | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n/a | n/a | affected |
|
No data.
No data.
No data available yet.
Remediation
Tracking
Advisories
| Source | ID | Title |
|---|---|---|
 EUVD |
EUVD-2025-23937 | GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An attacker with user-level access can exploit this misconfiguration by replacing or modifying the uninstaller (GPsetup64_17028.exe) with a malicious version. While the application itself runs in the user's context, the uninstaller is typically executed with administrative privileges when an administrator attempts to uninstall the software. By exploiting this flaw, an attacker could gain administrative privileges and execute arbitrary code in the context of the admin, resulting in privilege escalation. |
Metrics
No CVSS v4.0
Attack Vector Local
Attack Complexity Low
Privileges Required Low
Scope Unchanged
Confidentiality Impact High
Integrity Impact High
Availability Impact High
User Interaction None
No CVSS v3.0
No CVSS v2
This CVE is not in the KEV list.
Exploit prediction score: < 1% (0.264% probability within 30 days)
Exploitation poc
Automatable no
Technical Impact total
References
History
Aug 8, 2025 3:15 PM
Weaknesses updated. Scoring metrics updated
View changes
| Type | Values Removed | Values Added |
|---|---|---|
| Weaknesses | CWE-732 | |
| Metrics |
cvssV3_1
|
Aug 7, 2025 6:45 PM
Description updated. Added references
View changes
| Type | Values Removed | Values Added |
|---|---|---|
| Description | GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An attacker with user-level access can exploit this misconfiguration by replacing or modifying the uninstaller (GPsetup64_17028.exe) with a malicious version. While the application itself runs in the user's context, the uninstaller is typically executed with administrative privileges when an administrator attempts to uninstall the software. By exploiting this flaw, an attacker could gain administrative privileges and execute arbitrary code in the context of the admin, resulting in privilege escalation. | |
| References |
|
Subscriptions
No data.
Weaknesses